It is interesting to note that metformin, which is an insulin‐sensitizing agent used as a first‐line treatment of type 2 diabetes mellitus (T2DM), has been shown to increase the circulating level of GDF15.10, 79. This evidence concerns the gene GDF15 and type 2 diabetes mellitus.